Published in Int J Hepatol on April 18, 2013
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. J Transl Med (2015) 0.84
Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol (2016) 0.75
Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis. Int J Mol Sci (2015) 0.75
Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chin J Cancer (2015) 0.75
[Hepatocellular tumours in noncirrhotic liver tissue]. Pathologe (2015) 0.75
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93
Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet (2002) 2.85
Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet (1999) 2.51
Changing trends in malignant transformation of hepatocellular adenoma. Gut (2011) 2.28
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology (2009) 2.20
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology (2009) 2.00
Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol (1989) 1.78
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology (2009) 1.70
Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. Gastroenterology (1997) 1.67
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol (2004) 1.56
Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology (2000) 1.54
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology (2005) 1.52
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) (2010) 1.51
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr (1997) 1.50
Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab (2004) 1.46
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol (2009) 1.44
Clinical and radiologic manifestations of congenital extrahepatic portosystemic shunts: a comprehensive review. Radiographics (2011) 1.37
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med (2005) 1.33
Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg (2005) 1.30
Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology (1998) 1.29
Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology (2003) 1.28
Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology (2004) 1.26
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology (2003) 1.22
Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology (2007) 1.21
Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr (2011) 1.20
Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg (2010) 1.16
Congenital hepatic fibrosis: CT findings in 18 adults. Radiology (2004) 1.15
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes (2010) 1.13
Malignant transformation of hepatic adenomas. Mod Pathol (2008) 1.13
2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res (2003) 1.08
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol (2012) 1.05
Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut (2008) 0.96
Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int (2012) 0.96
Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Genes Chromosomes Cancer (2004) 0.96
Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med (2008) 0.95
Anabolic steroid-induced hepatic adenomas with spontaneous haemorrhage in a bodybuilder. Aust N Z J Surg (2000) 0.91
Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut (2007) 0.90
Nodular lesions associated with abnormal liver circulation. Intervirology (2004) 0.89
Danazol-induced hepatocellular adenomas. A case report and review of the literature. Arch Pathol Lab Med (1991) 0.88
Association of adenoma and focal nodular hyperplasia: experience of a single French academic center. Comp Hepatol (2003) 0.88
Hepatocellular adenomas in men: MRI findings in four patients. J Magn Reson Imaging (2005) 0.88
Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver. Eur J Gastroenterol Hepatol (2006) 0.88
Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol (2006) 0.88
A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod Pathol (2012) 0.88
Association of multiple liver cell adenomas with spontaneous intrahepatic portohepatic shunt. Abdom Imaging (1994) 0.87
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87
Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther (2011) 0.87
Liver cell adenoma in a 26-year-old man. J Nippon Med Sch (2001) 0.86
Hepatocellular adenoma with malignant alteration. Hepatogastroenterology (2007) 0.85
Liver tumours in patients with Fanconi anaemia: a report of three cases. Eur J Gastroenterol Hepatol (2008) 0.85
The identification of small nodules in liver adenomatosis. J Hepatol (2003) 0.85
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver. J Gastroenterol (2003) 0.84
Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol (1992) 0.84
Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. Histopathology (2012) 0.83
Pigmented liver cell adenoma in two male patients. Am J Surg Pathol (2000) 0.82
Obliterative portal venopathy: findings at CT imaging. Radiology (2012) 0.82
Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case. Surg Today (2011) 0.82
Hepatocellular adenoma and polycystic ovary syndrome. Liver Int (2003) 0.82
Pigmented hepatocellular adenoma: report of a case. Surg Today (2011) 0.82
Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J Hepatol (2002) 0.82
Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol (2010) 0.81
Hepatocellular adenoma in advanced-stage fatty liver disease. Eur J Gastroenterol Hepatol (2009) 0.81
Hepatocellular adenoma in a male with familial adenomatous polyposis coli. J Hepatobiliary Pancreat Surg (2009) 0.81
Hepatic adenomatosis--a rare double complication of multiple adenoma rupture and malignant transformation. Indian J Gastroenterol (2006) 0.80
Liver-cell adenoma in an epileptic man on barbiturates. Histol Histopathol (1989) 0.79
Regenerative nodules in patients with chronic Budd-Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT. Eur J Radiol (2009) 0.79
[Malignant transformation of hepatocellular adenoma in men]. Gastroenterol Clin Biol (2010) 0.78
Giant hepatocellular adenoma presenting with chronic iron deficiency anemia. Am J Gastroenterol (2006) 0.77
Hepatocellular adenoma in men: a rare cause for liver resection. Am Surg (2011) 0.77
Ruptured liver cell adenoma in man: great fortune in misfortune. Acta Chir Belg (2010) 0.77
An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol (2010) 0.77
[Pigmented hepatocellular adenoma of the liver caused by long-term use of phenobarbital]. Rozhl Chir (2003) 0.77
Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis. Diabetes Care (2012) 0.77
Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities. Jpn J Radiol (2009) 0.77
Liver cell adenomas and portosystemic shunt. Gastroenterol Clin Biol (2008) 0.77
Multiple hepatocellular adenomas associated with long-term carbamazepine. Histopathology (1999) 0.76
Hepatocellular adenomas associated with hepatic granulomas: experience in five cases. Case Rep Gastroenterol (2012) 0.76
Incidence of liver abnormalities in Fanconi anemia patients. Am J Hematol (2012) 0.76
[Polycystic ovary syndrome and hepatocellular adenoma related to long-term use of sodium valproate in a young woman]. No To Hattatsu (2006) 0.76
Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity. BMJ Case Rep (2010) 0.76
Multiple black hepatocellular adenomas in a male patient. Eur J Gastroenterol Hepatol (2000) 0.76
Giant hepatic adenoma with atypical features in a patient on oxcarbazepine therapy. J Pediatr Surg (2008) 0.76
Liver cell adenoma with co-existing hepatic granulomas in an HIV-positive patient. Indian J Gastroenterol (2006) 0.76
Simultaneous resection of liver cell adenomas and an intrahepatic portosystemic venous shunt with elevation of serum PIVKA-II level. J Gastroenterol (2006) 0.76
Large benign hepatocellular nodules in cirrhosis due to chronic venous outflow obstruction: diagnostic confusion with hepatocellular carcinoma. Transplant Proc (2010) 0.76
Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure. Pediatr Cardiol (2010) 0.75
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology (2005) 9.44
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet (2012) 6.65
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology (2006) 5.46
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature (2008) 5.38
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology (2008) 5.28
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology (2007) 4.73
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol (2006) 4.42
Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology (2008) 3.67
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology (2007) 3.18
Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology (2007) 3.12
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun (2013) 3.06
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00
Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet (2002) 2.85
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg (2006) 2.70
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology (2014) 2.68
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology (2010) 2.58
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology (2013) 2.37
Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology (2009) 2.23
[Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol (2002) 2.22
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology (2009) 2.20
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med (2011) 2.03
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol (2008) 1.98
Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest (2005) 1.96
Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys (2009) 1.87
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.86
A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology (2011) 1.84
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. J Clin Oncol (2009) 1.82
Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol (2005) 1.79
Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg (2005) 1.65
Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol (2012) 1.65
Real-time MR temperature mapping of rabbit liver in vivo during thermal ablation. Magn Reson Med (2003) 1.62
Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology (2008) 1.58
Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases. Surgery (2010) 1.56
Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab. Cancer Treat Rev (2010) 1.56
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology (2009) 1.55
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology (2005) 1.52
An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol (2012) 1.51
Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg (2010) 1.50
Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.48
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal. Clin Transplant (2002) 1.48
Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr (2007) 1.47
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.47
Hepatocellular adenomas. Liver Int (2008) 1.47
Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab (2004) 1.46
Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie. Ann Surg Oncol (2015) 1.46
Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg (2008) 1.41
Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis (2008) 1.39
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology (2004) 1.38
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem (2007) 1.36
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis (2011) 1.35
Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol (2003) 1.35
Subtype classification of hepatocellular adenoma. Dig Surg (2010) 1.33
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol (2011) 1.32
A kernel-based integration of genome-wide data for clinical decision support. Genome Med (2009) 1.26
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol (2011) 1.25
Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis. Am J Surg Pathol (2006) 1.23
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology (2003) 1.22
Real-time monitoring of radiofrequency ablation of rabbit liver by respiratory-gated quantitative temperature MRI. J Magn Reson Imaging (2006) 1.22
Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol (2007) 1.21
Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data. J Ultrasound Med (2013) 1.21
Stability of real-time MR temperature mapping in healthy and diseased human liver. J Magn Reson Imaging (2004) 1.21
Congenital hyperinsulinism. Early Hum Dev (2010) 1.21
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer (2006) 1.21
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Hum Pathol (2012) 1.20
Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg (2005) 1.18
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol (2009) 1.18
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg (2010) 1.18
Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med (2003) 1.17
Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg (2004) 1.17
Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant (2007) 1.17